“
TL;DR
However, among participants who met guideline-based criteria for treatment, the cumulative percentage who initiated therapy was 62% and did not differ significantly by race.
JAMA Network Open · 8 authors, 8 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
However, among participants who met guideline-based criteria for treatment, the cumulative percentage who initiated therapy was 62% and did not differ significantly by race.
However, among participants who met guideline-based criteria for treatment, the cumulative percentage who initiated therapy was 62% and did not differ significantly by race. Major adverse liver outcomes were rare, with an overall incidence of 0.1 per 100 person-years. Limitations include the cohort's linkage to specialty liver clinics, which may limit generalizability, and the inability to measure unmeasured factors like health literacy or patient preference.